期刊
ANTIVIRAL THERAPY
卷 17, 期 1, 页码 175-191出版社
INT MEDICAL PRESS LTD
DOI: 10.3851/IMP2060
关键词
-
资金
- MedImmune
- Novartis
- Adamas
- ADMA
The treatment of respiratory viruses is extremely challenging in haematopoietic stem cell transplant (HSCT) recipients. Outcomes related to these infections have improved over the past decade. More recently, studies have looked at respiratory virus epidemiology using molecular assays to understand the wide range of diseases in HSCT recipients. The emergence of pandemic H1N1 in 2009 encouraged implementation of molecular assays in many clinical laboratories and broadened influenza resistance detection. Finally, new drugs have been developed to treat influenza virus, respiratory syncytial virus, parainfluenza virus and adenovirus with some promising results.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据